[1]
D. Osman, M. L. Maroto, F. Kinsella, and V. Murthy, “Venetoclax-Azacitidine Salvage Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Single-Center Experience”, J Hematol, vol. 14, no. 2, pp. 105–108, Apr. 2025, doi: 10.14740/jh1362.